DARPP-32 expression in rat brain after electroconvulsive stimulation

Brain Research

Volumn 1179, Issue 1, 2007, Pages 35-41

  Rosa, Daniela V F ^a   Souza, Renan P ^a   Souza, Bruno R ^a   Motta, Bernardo S ^a   Caetano, Fernando ^a   Jornada, Luciano K ^b   Feier, Gustavo ^b   Gomez, Marcus V ^a   Quevedo, João ^b   Romano Silva, Marco A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

DARPP 32; Depression; Electroconvulsive stimulation; Electroconvulsive therapy; Schizophrenia

Indexed keywords

PHOSPHOPROTEIN DARPP 32;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; ELECTROCONVULSIVE THERAPY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT;

ANIMALS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CEREBELLUM; CEREBRAL CORTEX; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; ELECTRIC STIMULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROSHOCK; HIPPOCAMPUS; LUMINESCENCE; MALE; NEOSTRIATUM; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 35549008451     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.08.043     Document Type: Article

References (47)

1. Abrams R. Electroconvulsive Therapy (1998), Oxford University Press, Oxford
2. Altar C.A., Laeng P., Jurata L.W., Brockman J.A., Lemire A., Bullard J., Bukhman Y.V., Young T.A., Charles V., and Palfreyman M.G. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J. Neurosci. 17 24 (11) (2004) 2667-2677
3. Albert K.A., Hemmings Jr. H.C., Adamo A.I., Potkin S.G., Akbarian S., Sandman C.A., Cotman C.W., Bunney W.E., and Greengard P. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch. Gen. Psychiatry 59 (2002) 705-712
4. Barichello T., Bonatto F., Agostinho F.R., Reinke A., Moreira J.C., Dal-Pizzol F., Izquierdo I., and Quevedo J. Structure-related oxidative damage in rat brain after acute and chronic electroshock. Neurochem. Res. 29 (2004) 1749-1753
5. Belkhiri A., Zaika A., Pidkovka N., Knuutila S., Moskaluk C., and El-Rifai W. Darpp-32: a novel antiapoptotic gene in upper gastrointestinal carcinomas. Cancer Res. 65 (2005) 6583-6592
6. Bibb J.A., Snyder G.L., Nishi A., Yan Z., Meijer L., Fienberg A.A., Tsai L.H., Kwon Y.T., Girault J.A., Czernik A.J., Huganir R.L., Hemmings Jr. H.C., Nairn A.C., and Greengard P. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402 (1999) 669-671
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
8. Conti B., Maier R., Barr A.M., Morale M.C., Lu X., Sanna P.P., Bilbe G., Hoyer D., and Bartfai T. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol. Psychiatry 12 (2007) 167-189
9. Dranovsky A., and Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol. Psychiatry 59 (2006) 1136-1143
10. Dremencov E., Gur E., Lerer B., and Newman M.E. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 (2002) 1029-1034
11. El-Rifai W., Smith Jr. M.F., Li G., Beckler A., Carl V.S., Montgomery E., Knuutila S., Moskaluk C.A., Frierson H.F., and Powell S.M. Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. Cancer Res. 62 (2002) 4061-4064
12. Fang H., Chartier J., Sodja C., Desbois A., Ribecco-Lutkiewicz M., Walker P.R., and Sikorska M. Transcriptional activation of the human brain-derived neurotrophic factor gene promoter III by dopamine signaling in NT2/N neurons. J. Biol. Chem. 278 (2003) 26401-26409
13. Fochtmann L.J. Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacol. Bull. 30 (1994) 321-444
14. Fujita A., Nakaaki S., Segawa K., Azuma H., Sato K., Arahata K., Otsuki K., Hori M., Mochida Y., Uchida M., Yamada T., Nakamura C., Akechi T., and Furukawa T.A. Memory, attention, and executive functions before and after sine and pulse wave electroconvulsive therapies for treatment-resistant major depression. J. ECT 22 2 (2006) 107-112
15. Garcia-Jimenez C., Zaballos M.A., and Santisteban P. DARPP-32 (dopamine and 3',5'-cyclic adenosine monophosphate-regulated neuronal phosphoprotein) is essential for the maintenance of thyroid differentiation. Mol. Endocrinol. 19 (2005) 3060-3072
16. Greengard P. The neurobiology of dopamine signaling. Biosci. rep. 21 3 (2001) 247-269
17. Greengard P., Allen P.B., and Nairn A.C. Beyond the dopamine receptor: the DARPP-32/Protein phosphatase-1 cascade. Neuron 23 (1999) 435-447
18. Guitary X., and Nestler E.J. Chronic administration of lithium or other antidepressants increases levels of DARPP-32 in rat frontal cortex. J. Neurochem. 59 (1992) 1164-1167
19. Gur E., Dremencov E., Garcia F., van de Kar L.D., Lerer B., and Newman M.E. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus. Brain Res. 952 (2002) 52-60
20. Hansen C., Greengard P., Nairn A.C., Andersson T., and Vogel W.F. Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. Exp. Cell Res. 312 (2006) 4011-4018
21. Heyser C.J., Fienberg A.A., Greengard P., and Gold L.H. DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. Brain Res. 867 1-2 (2000) 122-130
22. Kuppers E., and Beyer C. Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells. Neuroreport 12 (2001) 1175-1179
23. Leiner H.C., Leiner A.L., and Dow R.S. Reappraising the cerebellum: what does the hindbrain contribute to the forebrain?. Behav. Neurosci. 103 5 (1989) 998-1008
24. Newman M.E., Gur B., and Shapira Lerer B. Neurochemical mechanism of action of ECS: evidence from in vivo studies. J. ECT 14 (1998) 151-171
25. Newton S.S., Collier E.F., Hunsberger J., Adams D., Terwilliger R., Selvanayagam E., and Duman R.S. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J. Neurosci. 26 23 (34) (2003) 10841-10851
26. Newton S.S., Girgent M.J., Collier E.F., and Duman R.S. Electroconvulsive seizure increases adult hippocampal angiogenesis in rats. Eur. J. Neurosci. 24 3 (2006) 819-828
27. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 (1995) 7539-7547
28. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16 (1996) 2365-2372
29. Nomikos G.G., Zia A.P., Damsma G., and Fibiger H.C. Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: an in vivo microdialysis study. Neuropsychopharmacology 4 (1991) 65-69
30. Papakostas G.I. Dopaminergic-based pharmacotherapies for depression. Eur. Neuropsychopharmacol. 16 (2006) 391-402
31. Ploski J.E., Newton S.S., and Duman R.S. Electroconvulsive seizure-induced gene expression profile of the hippocampus dentate gyrus granule cell layer. J. Neurochem. 99 (2006) 1122-1132
32. Rosen Y., Resinik I., Sluvis A., Kaplan D., and Mester R. The significance of the nitric oxide in electro-convulsive therapy: a proposed neurophysiological mechanism. Med. Hypotheses 60 (2003) 424-429
33. Shen H., Numachi Y., Yoshida S., Toda S., Awata S., Matsuoka H., and Sato M. Electroconvulsive shock regulates serotonin transporter mRNA expression in rat raphe nucleus. Psychiatry Clin. Neurosci. 55 (2001) 75-77
34. Souza B.R., Souza R.P., Rosa D.V.F., Guimarães M.M., Correa H., and Romano-Silva M.A. Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia. Dialogues Clin. Neurosci. 7 4 (2006) 95-100
35. Souza R.P., Rosa D.V., Souza B.R., and Romano-Silva M.A. Darpp32. AfCS-Nature Molecule Pages (2006) 10.1038/mp.a000752.01
36. Stroppolo A., Guinea B., Tian C., Sommer J., and Ehrlich M.E. Role of phosphatidylinositide 3-kinase in brain-derived neurotrophic factor-induced DARPP-32 expression in medium size spiny neurons in vitro. J. Neurochem. 79 (2001) 1027-1032
37. Svenningsson P., Tzavara E.T., Liu F., Fienberg A.A., Nomikos G.G., and Greengard P. DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3188-3193
38. 1B receptor function by p11 in depression-like states. Science 311 (2006) 77-80
39. The UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. The Lancet 361 (2003) 799-808
40. Thienhaus O.J., Margletta S., and Bennet J.A. A study of the clinical efficacy of maintenance ECT. J. Clin. Psychiatry 51 (1990) 141-144
41. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4350-4354
42. Yagasaki Y., Numakawa T., Kumamaru E., Hayashi T., Su T., and Kunugi H. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J. Biol. Chem. 281 (2006) 12941-12949
43. Yoshida K., Higushi H., Kamata M., Yoshimoto M., Shimizu T., and Hishikawa Y. Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 21 (1997) 707-715
44. Yoshida K., Higushi H., Kamata M., Yoshimoto M., Shimizu T., and Hishikawa Y. Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroytryptaminergic neurotransmission in the frontal cortex of rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 22 (1998) 435-444
45. Zetterstrom T.S., Pei Q., and Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res. Mol. Brain Res. 57 (1998) 106-110
46. Zis A.P., Nomikos G.G., Damsma G., and Fibiger H.C. In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in the rat striatum. Psychopharmacology 103 (1991) 343-350
47. Zis A.P., Nomikos G.G., Brown E.E., Damsma G., and Fibiger H.C. Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus. Neuropsychopharmacology 7 (1992) 189-195